HK1180230A1 - Use of a fermented soy extract for manufacture of a prebiotic composition - Google Patents

Use of a fermented soy extract for manufacture of a prebiotic composition

Info

Publication number
HK1180230A1
HK1180230A1 HK13107557.5A HK13107557A HK1180230A1 HK 1180230 A1 HK1180230 A1 HK 1180230A1 HK 13107557 A HK13107557 A HK 13107557A HK 1180230 A1 HK1180230 A1 HK 1180230A1
Authority
HK
Hong Kong
Prior art keywords
manufacture
prebiotic composition
fermented soy
soy extract
extract
Prior art date
Application number
HK13107557.5A
Other languages
English (en)
Chinese (zh)
Inventor
庄明恒
游丞德
路孔明
Original Assignee
中天生物科技股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 中天生物科技股份有限公司 filed Critical 中天生物科技股份有限公司
Publication of HK1180230A1 publication Critical patent/HK1180230A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • A61K2035/115Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK13107557.5A 2010-07-20 2013-06-27 Use of a fermented soy extract for manufacture of a prebiotic composition HK1180230A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36588710P 2010-07-20 2010-07-20
PCT/CN2011/001188 WO2012009961A1 (fr) 2010-07-20 2011-07-20 Utilisation d'un extrait de soja fermenté dans la fabrication d'une composition prébiotique

Publications (1)

Publication Number Publication Date
HK1180230A1 true HK1180230A1 (en) 2013-10-18

Family

ID=45496476

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13107557.5A HK1180230A1 (en) 2010-07-20 2013-06-27 Use of a fermented soy extract for manufacture of a prebiotic composition

Country Status (12)

Country Link
US (1) US9259450B2 (fr)
EP (1) EP2595641B1 (fr)
JP (1) JP6005041B2 (fr)
KR (1) KR101849424B1 (fr)
CN (1) CN103079583B (fr)
BR (1) BR112013001369B1 (fr)
CA (1) CA2805319C (fr)
HK (1) HK1180230A1 (fr)
MY (1) MY170190A (fr)
SG (2) SG187554A1 (fr)
TW (1) TWI552685B (fr)
WO (1) WO2012009961A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6333509B2 (ja) * 2012-06-22 2018-05-30 雪印メグミルク株式会社 還元された桂皮酸類縁化合物含有画分の製造方法
JP6605319B2 (ja) * 2015-12-17 2019-11-13 株式会社ダイワ 乳酸菌含有加工食品の製造方法
WO2017167213A1 (fr) * 2016-03-30 2017-10-05 Microbio Co., Ltd. Polythérapie anticancéreuse à base de modulateurs des points de contrôle immunitaire et de produits de fermentation générés par un microbiote symbiotique

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60134386D1 (de) * 2001-03-21 2008-07-24 Microbio Co Ltd Verfahren zur Hemmung von Krebswachstum mit einem fermentierten Soja- Extrakt
US20020182274A1 (en) * 2001-03-21 2002-12-05 Kung-Ming Lu Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
US20040219237A1 (en) * 2002-06-25 2004-11-04 Kung-Ming Lu Process of using fermented Glycine max (L.) extract for enhancing natural killer cell activity and inhibitory activities to GABA and glutamate receptor binding
EP1512407A1 (fr) * 2003-09-02 2005-03-09 Microbio Company, Ltd. Utilisation d'un extrait fermenté de Glycine max (L.) pour
CA2470090A1 (fr) * 2004-06-18 2005-12-18 Bio-K Plus International Inc. Bacteries lactiques et leurs usages dans la prevention de diarrhee associee aux antibiotiques
CA2690058A1 (fr) * 2006-06-09 2007-12-13 9205-5961 Quebec Inc. Compositions probiotiques derivees de produits laitiers et leurs utilisations
KR100926170B1 (ko) * 2007-10-05 2009-11-10 정재수 엽산이 혼입된 대두 발효 고분자물질 및 이를 포함하는조성물
CN101692876A (zh) * 2009-09-18 2010-04-14 姜波 仔猪饲料

Also Published As

Publication number Publication date
BR112013001369A2 (pt) 2020-10-06
TWI552685B (zh) 2016-10-11
EP2595641A4 (fr) 2014-01-01
SG10201505609YA (en) 2015-09-29
KR20130136434A (ko) 2013-12-12
MY170190A (en) 2019-07-09
JP6005041B2 (ja) 2016-10-12
BR112013001369B1 (pt) 2022-03-22
KR101849424B1 (ko) 2018-05-31
CN103079583A (zh) 2013-05-01
SG187554A1 (en) 2013-03-28
TW201218965A (en) 2012-05-16
CN103079583B (zh) 2015-03-25
CA2805319A1 (fr) 2012-01-26
EP2595641A1 (fr) 2013-05-29
WO2012009961A1 (fr) 2012-01-26
JP2013535439A (ja) 2013-09-12
EP2595641B1 (fr) 2018-03-14
US9259450B2 (en) 2016-02-16
US20120058104A1 (en) 2012-03-08
CA2805319C (fr) 2020-06-30

Similar Documents

Publication Publication Date Title
IL222199A0 (en) Process for preparation of dopo-derived compounds and compositions thereof
HK1178465A1 (en) Composition for improving condition of skin
EP2560484A4 (fr) Composition pharmaceutique de nanoparticules
EP2668281A4 (fr) Compositions et méthodes pour la production de succinate
GB2493441B (en) Leg prosthesis
GB201011991D0 (en) Improvements relating to valves
EP2563768A4 (fr) Préparation of fébuxostat
HK1180230A1 (en) Use of a fermented soy extract for manufacture of a prebiotic composition
PL2785769T3 (pl) Kompozycja utwardzacza epoksydowego i kompozycje od niej pochodzące
SI2407155T1 (sl) Preparati na osnovi inekalcitola
RS63165B1 (sr) Prirodno lekovito jedinjenje
HK1178025A1 (en) Extract of teas
PL3097920T3 (pl) Kompozycja medyczna zawierająca ekstrakt stauntonia hexaphylla
EP2654770A4 (fr) Compositions pharmaceutiques de ténectéplase
PL2513060T3 (pl) Krystaliczna postać α karbabenzopirydu
GB0922023D0 (en) Preparation of n-monofluoroalkyl compounds
HK1183207A1 (en) Extract of teas
HK1179120A1 (en) Extract of teas
EP2702991A4 (fr) Composition d'entacopone
EP2459540A4 (fr) Préparation du fipamézole
AU2010903172A0 (en) Use of a nutraceutical composition
PL392895A1 (pl) Preparat o właściwościach prebiotycznych
PL392894A1 (pl) Preparat o właściwościach prebiotycznych
GB201015361D0 (en) Compositions for application to a condom
HU1000328D0 (en) Nanostuctured indometachine compositions and process for their preparation